Endostatin gene transfer in murine lung carcinoma cells induces vascular endothelial growth factor secretion resulting in up-regulation of in vivo tumorigenecity

Cancer Letters

Volumn 232, Issue 2, 2006, Pages 262-271

  Cui, Ri ^a   Takahashi, Kazuhisa ^a   Takahashi, Fumiyuki ^a   Tanabe, Kenneth K ^b   Fukuchi, Yoshinosuke ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Endostatin (ED); Lung cancer; Mouse; Tumorigenecity; Vascular endothelial growth factor (VEGF)

Indexed keywords

ENDOSTATIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE TRANSFER; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LEWIS CARCINOMA; LUNG CARCINOMA; MOLECULAR CLONING; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; STAINING; TUMOR GROWTH; UMBILICAL VEIN; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; CYCLOHEXANES; ENDOSTATINS; ENDOTHELIAL CELLS; GENE TRANSFER, HORIZONTAL; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; RNA, MESSENGER; SESQUITERPENES; TRANSFECTION; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; MURINAE;

EID: 31644434782     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.02.045     Document Type: Article

References (30)

1. R. Bicknell, and A. Harris Novel growth regulatory factors and tumor angiogenesis Eur. J. Cancer 1991 1991 781 784
2. D. Hanahan, and J. Folkman Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 1996 353 363
3. J. Folkman, K. Watson, D. Ingber, and D. Hanahan Induction of angiogenesis during the transition from hyperplasia to neoplasia Nature 339 1989 58 61
4. J. Distler, A. Hirth, M. Kurowska-Stolarska, R. Gay, S. Gay, and O. Distler Angiogenic and angiostatic factors in the molecular control of angiogenesis Q. J. Nucl. Med. 47 2003 149 161
5. H. Aikawa, H. Takahashi, S. Fujimura, M. Sato, C. Endo, A. Sakurada, T. Kondo, T. Tanita, Y. Matsumura, S. Ono, Y. Saito, and M. Sagawa Immunohistochemical study on tumor angiogenic factors in non-small cell lung cancer Anticancer Res. 19 1999 4305 4309
6. G. Callagy, E. Dimitriadis, J. Harmey, D. Bouchier-Hayes, M. Leader, and E. Kay Immunohistochemical measurement of tumor vascular endothelial growth factor in breast cancer. A more reliable predictor of tumor stage than microvessel density or serum vascular endothelial growth factor Appl. Immunohistochem. Mol. Morphol. 8 2000 104 109
7. G. Fontanini, S. Vignati, L. Boldrini, S. Chine, V. Silverstri, M. Lucchi, A. Mussi, C.A. Angeletti, and G. Bevilacqua Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma Clin. Cancer Res. 3 1997 861 865
8. A. Giatromanolaki Differential expression of angiogenic and of vascular survival factors in non-small cell lung cancer (NSCLC) Adv. Exp. Med. Biol. 476 2000 291 295
9. T. Lantzsch, L. Hefler, U. Krause, A. Kehl, C. Goepel, H. Koelbl, J. Dunst, and D. Lampe The correlation between immunohistochemically-detected markers of angiogenesis and serum vascular endothelial growth factor in patients with breast cancer Anticancer. Res. 22 2002 1925 1928
10. J. Mattern, R. Koomaqi, and M. Volm Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumor cell proliferation in human epidermoid carcinoma Br. J. Cancer 73 1996 931 934
11. S. Sridhar, and F. Shepherd Targeting angiogenesis: a review of angiogenesis inhibitors in the treatment of lung cancer Lung Cancer 42 2003 S81 S91
12. M. O'Reilly, T. Boehm, Y. Shing, N. Fukai, G. Vasios, W. Lane, E. Flynn Birkhead, B. Olsen, and J. Folkman Endostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 88 1997 277 285
13. M. O'Reilly, and L. Holmgren Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma Cell 79 1994 315 328
14. W. Wen, M. Moses, D. Wiedershain, J. Arbiser, and J. Folkman The generation of endostatin is mediated by elastase Cancer Res. 59 1999 6052 6056
15. M. Ferreras, U. Felbor, T. Lenhard, B. Olsen, and J. Delasisse Generation and degradation of human endostatin proteins by various proteinases FEBS Lett. 486 2000 247 251
16. U. Zatterstrom, U. Felbor, N. Fukai, and R. Olsen Collagen XVIII/endostatin structure and functional role in angiogenesis Cell Struct. Funct. 25 2000 97 101
17. N. Yamaguchi, B. Anand-Apte, M. Lee, T. Sasaki, N. Fukai, R. Shapiro, I. Que, C. Lowik, R. Timpl, and B. Olsen Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding Eur. Mol. Biol. Org. J. 18 1999 4414 4423
18. J. Szary, and S. Szala Intra-tumoral administration of naked plasmid DNA encoding mouse endostatin inhibits renal carcinoma growth Int. J. Cancer 91 2001 835 839
19. M. Rehn, T. Veikkola, E. Kukk-Valdre, H. Nakamura, N. IImonen, C. Lombardo, T. Pihlajaniemi, K. Alitalo, and K. Vuori Interaction of endostatin with integrins implicated in angiogenesis Proc. Natl. Acad. Sci. USA 98 2001 1024 1029
20. D. Sorensen, and T. Read Delivery of endostatin in experimental cancer therapy Int. J. Exp. Pathol. 83 2002 265 274
21. K. Eriksson, P. Magnusson, J. Dixelius, L. Claesson-Welsh, and M. Cross Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and VEGF without interfering with specific intracellular signal transduction pathways FEBS Lett. 536 2003 19 24
22. R. Herbst, K. Hess, H. Tran, J. Tseng, N. Mullani, C. Charnsangavej, T. Madden, D. Davis, D. McConkey, M. O'Reilly, L. Ellis, J. Pluda, W. Hong, and J. Abbruzzese Phase I study of recombinant human endostatin in patients with advanced solid tumors J. Clin. Oncol. 20 2002 3792 3803
23. J. Thomas, R. Arzoomanian, D. Alberti, R. Marnocha, F. Lee, A. Friedl, K. Tutsch, A. Dresen, P. Geiger, J. Pluda, W. Fogler, J. Schiller, and G. Wilding Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors J. Clin. Oncol. 15 2003 223 231
24. B. Sauter, O. Martinet, W. Zhang, J. Mandeli, and S. Woo Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases Proc. Natl. Acad. Sci. USA 97 2000 4802 4807
25. I. Ding, J. Sun, B. Fenton, W. Liu, P. Kimsely, P. Okunieff, and W. Min Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas Cancer Res. 61 2001 526 531
26. A. Calvo, A. Feldman, S. Libutti, and J. Green Adenovirus-mediated endostatin delivery results in inhibition of mammary gland tumor growth in C3(1)/SV40 T-antigen transgenic mice Cancer Res. 62 2002 3934 3938
27. W. Wen, M. Moses, D. Wiedershain, J. Arbiser, and J. Fakman The generation of endostatin is mediated by elastase Cancer Res. 59 1999 6052 6056
28. S. Yoon, H. Eto, C. Lin, H. Nakamura, T. Pawlik, S. Song, and K. Tanabe Mouse endostatin inhibits the formation of lung and liver metastases Cancer Res. 59 1999 6251 6256
29. A. Feldman, L. Tamarkin, G. Paciotti, B. Simpson, W. Linehan, J. Yang, W. Fogler, E. Turner, H.J. Alexander, and S. Libutti Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer Clin. Cancer Res. 6 2000 4628 4634
30. Y. Saijo, M. Tanaka, M. Miki, K. Usui, T. Suzuki, M. Maemondo, X. Hong, R. Tazawa, T. Kikuchi, K. Matsushima, and T. Nukiwa Proinflammatory cytokine IL-1b promotes tumor growth of Lewis Lung Carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction J. Immunol. 169 2002 469 475